LexisNexis Home Products & Services Customer Service Center Company Information Alliance Partners LexisNexis Bookstore Search


  Current Subscribers
  
LexisNexis Litigation News and Reports
Non Subscribers: Find a product that's right for you!
Expert Witness Summary Directory

Buy NowBuy Now

Contact A Sales RepContact A Sales Rep



 
   
 
Legal News
Intellectual Property Law
Sunday, December 06, 2009
 
Delaware Federal Judge Says Glaucoma Drug Patents Are Valid, Enforceable
WILMINGTON, Del. - A federal judge in Delaware concluded Oct. 23 that an abbreviated new drug application (ANDA) by several pharmaceutical makers would infringe a series of patents relating to the glaucoma drug Alphagan P (In re: Brimonidine Patent Litigation, No. 07-md-1866 GMS, D. Del.). From Mealey's Litigation Report: Patents

Related Court Documents on MealeysOnline:

 

View Headlines by Topic

View Headlines by Jurisdiction

BREAKING NEWS 
> View all Breaking News    

More Intellectual Property Law Headlines

Related Products